{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T07:30:22Z","timestamp":1788852622861,"version":"build-2803163510"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,4,5]],"date-time":"2023-04-05T00:00:00Z","timestamp":1680652800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,5]],"date-time":"2023-04-05T00:00:00Z","timestamp":1680652800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Johann Wolfgang Goethe-Universit\u00e4t, Frankfurt am Main"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Epidemiol"],"published-print":{"date-parts":[[2023,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Treatment concepts in oncology are becoming increasingly personalized and diverse. Successively, changes in standards of care mandate continuous monitoring of patient pathways and clinical outcomes based on large, representative real-world data. The German Cancer Consortium\u2019s (DKTK) Clinical Communication Platform (CCP) provides such opportunity. Connecting fourteen university hospital-based cancer centers, the CCP relies on a federated IT-infrastructure sourcing data from facility-based cancer registry units and biobanks. Federated analyses resulted in a cohort of 600,915 patients, out of which 232,991 were incident since 2013 and for which a comprehensive documentation is available. Next to demographic data (i.e., age at diagnosis: 2.0% 0\u201320\u00a0years, 8.3% 21\u201340\u00a0years, 30.9% 41\u201360\u00a0years, 50.1% 61\u201380\u00a0years, 8.8% 81+\u2009years; and gender: 45.2% female, 54.7% male, 0.1% other) and diagnoses (five most frequent tumor origins: 22,523 prostate, 18,409 breast, 15,575 lung, 13,964 skin\/malignant melanoma, 9005 brain), the cohort dataset contains information about therapeutic interventions and response assessments and is connected to 287,883 liquid and tissue biosamples. Focusing on diagnoses and therapy-sequences, showcase analyses of diagnosis-specific sub-cohorts (pancreas, larynx, kidney, thyroid gland) demonstrate the analytical opportunities offered by the cohort\u2019s data. Due to its data granularity and size, the cohort is a potential catalyst for translational cancer research. It provides rapid access to comprehensive patient groups and may improve the understanding of the clinical course of various (even rare) malignancies. Therefore, the cohort may serve as a decisions-making tool for clinical trial design and contributes to the evaluation of scientific findings under real-world conditions.<\/jats:p>","DOI":"10.1007\/s10654-023-00990-w","type":"journal-article","created":{"date-parts":[[2023,4,5]],"date-time":"2023-04-05T05:58:38Z","timestamp":1680674318000},"page":"573-586","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Profile of the multicenter cohort of the German Cancer Consortium\u2019s Clinical Communication Platform"],"prefix":"10.1007","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6266-8987","authenticated-orcid":false,"given":"Daniel","family":"Maier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5446-7170","authenticated-orcid":false,"given":"J\u00f6rg Janne","family":"Vehreschild","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5995-2995","authenticated-orcid":false,"given":"Barbara","family":"Uhl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1778-8768","authenticated-orcid":false,"given":"Sandra","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Berger-Th\u00fcrmel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3670-0602","authenticated-orcid":false,"given":"Melanie","family":"Boerries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6039-6957","authenticated-orcid":false,"given":"Rickmer","family":"Braren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2083-7687","authenticated-orcid":false,"given":"Viktor","family":"Gr\u00fcnwald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1052-2692","authenticated-orcid":false,"given":"Boris","family":"Hadaschik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Palm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5784-7964","authenticated-orcid":false,"given":"Susanne","family":"Singer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Stuschke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Ju\u00e1rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Delpy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Lambarki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6717-605X","authenticated-orcid":false,"given":"Michael","family":"Hummel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e4cilia","family":"Engels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2374-5550","authenticated-orcid":false,"given":"Stefanie","family":"Andreas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2291-8245","authenticated-orcid":false,"given":"Nicola","family":"G\u00f6kbuget","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Ihrig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susen","family":"Burock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dietmar","family":"Keune","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelika","family":"Eggert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Keilholz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hagen","family":"Schulz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"B\u00fcttner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7017-3738","authenticated-orcid":false,"given":"Steffen","family":"L\u00f6ck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mechthild","family":"Krause","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirko","family":"Esins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Ressing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2166-3394","authenticated-orcid":false,"given":"Martin","family":"Schuler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Brandts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1808-5917","authenticated-orcid":false,"given":"Daniel P.","family":"Brucker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Husmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Oellerich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2451-1943","authenticated-orcid":false,"given":"Patrick","family":"Metzger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederik","family":"Voigt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna L.","family":"Illert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Theobald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Kindler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ursula","family":"Sudhof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Achim","family":"Reckmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Schwinghammer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Nasseh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilko","family":"Weichert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"von Bergwelt-Baildon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4463-8263","authenticated-orcid":false,"given":"Michael","family":"Bitzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nisar","family":"Malek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d6znur","family":"\u00d6ner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1443-2720","authenticated-orcid":false,"given":"Klaus","family":"Schulze-Osthoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8454-8716","authenticated-orcid":false,"given":"Stefan","family":"Bartels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1278-9438","authenticated-orcid":false,"given":"J\u00f6rg","family":"Haier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raimund","family":"Ammann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja Franziska","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd","family":"Guenther","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6632-8506","authenticated-orcid":false,"given":"Melanie","family":"Janning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8425-8356","authenticated-orcid":false,"given":"Bernd","family":"Kasper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7650-8527","authenticated-orcid":false,"given":"Sonja","family":"Loges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Stilgenbauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5058-1059","authenticated-orcid":false,"given":"Peter","family":"Kuhn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugen","family":"Tausch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvana","family":"Runow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Kerscher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Neumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Breu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1880-5555","authenticated-orcid":false,"given":"Martin","family":"Lablans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hubert","family":"Serve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,5]]},"reference":[{"key":"990_CR1","doi-asserted-by":"publisher","DOI":"10.1002\/1878-0261.12430","author":"S Joos","year":"2019","unstructured":"Joos S, Nettelbeck DM, Reil-Held A, et al. German Cancer Consortium (DKTK)\u2013A national consortium for translational cancer research. Mol Oncol. 2019. https:\/\/doi.org\/10.1002\/1878-0261.12430.","journal-title":"Mol Oncol"},{"key":"990_CR2","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.16063","author":"NJ Meropol","year":"2021","unstructured":"Meropol NJ, Donegan J, Rich AS. Progress in the application of machine learning algorithms to cancer research and care. JAMA Netw Open. 2021. https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.16063.","journal-title":"JAMA Netw Open"},{"key":"990_CR3","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.14723","author":"Q Yuan","year":"2021","unstructured":"Yuan Q, Cai T, Hong C, et al. Performance of a machine learning algorithm using electronic health record data to identify and estimate survival in a longitudinal cohort of patients with lung cancer. JAMA Netw Open. 2021. https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.14723.","journal-title":"JAMA Netw Open"},{"key":"990_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/s43018-021-00236-2","author":"O Morin","year":"2021","unstructured":"Morin O, Valli\u00e8res M, Braunstein S, et al. An artificial intelligence framework integrating longitudinal electronic health records with real-world data enables continuous pan-cancer prognostication. Nat Cancer. 2021. https:\/\/doi.org\/10.1038\/s43018-021-00236-2.","journal-title":"Nat Cancer"},{"key":"990_CR5","doi-asserted-by":"publisher","DOI":"10.1056\/nejmp1606181","author":"Z Obermeyer","year":"2016","unstructured":"Obermeyer Z, Emanuel EJ. Predicting the future\u2014big data, machine learning, and clinical medicine. N Engl J Med. 2016. https:\/\/doi.org\/10.1056\/nejmp1606181.","journal-title":"N Engl J Med"},{"key":"990_CR6","doi-asserted-by":"publisher","DOI":"10.1002\/1878-0261.12763","author":"A Berns","year":"2020","unstructured":"Berns A, Ringborg U, Celis JE, et al. Towards a cancer mission in Horizon Europe: recommendations. Mol Oncol. 2020. https:\/\/doi.org\/10.1002\/1878-0261.12763.","journal-title":"Mol Oncol"},{"key":"990_CR7","doi-asserted-by":"publisher","DOI":"10.1007\/s00761-017-0263-1","author":"CH Brandts","year":"2017","unstructured":"Brandts CH. Comprehensive Cancer Center in Deutschland: Aktueller Stand und zuk\u00fcnftige Entwicklungen. Onkologe. 2017. https:\/\/doi.org\/10.1007\/s00761-017-0263-1.","journal-title":"Onkologe"},{"key":"990_CR8","doi-asserted-by":"publisher","DOI":"10.3414\/ME14-01-0137","author":"M Lablans","year":"2015","unstructured":"Lablans M, Kadioglu D, Muscholl M, \u00dcckert F. Exploiting distributed, heterogeneous and sensitive data stocks while maintaining the owner\u2019s data sovereignty. Methods Inf Med. 2015. https:\/\/doi.org\/10.3414\/ME14-01-0137.","journal-title":"Methods Inf Med"},{"key":"990_CR9","doi-asserted-by":"publisher","DOI":"10.1200\/cci.17.00062","author":"M Lablans","year":"2018","unstructured":"Lablans M, Schmidt EE, \u00dcckert F. An architecture for translational cancer research as exemplified by the German Cancer Consortium. JCO Clin Cancer Inform. 2018. https:\/\/doi.org\/10.1200\/cci.17.00062.","journal-title":"JCO Clin Cancer Inform"},{"key":"990_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s12911-014-0123-5","author":"M Lablans","year":"2015","unstructured":"Lablans M, Borg A, \u00dcckert F. A RESTful interface to pseudonymization services in modern web applications. BMC Med Inform Decis Mak. 2015. https:\/\/doi.org\/10.1186\/s12911-014-0123-5.","journal-title":"BMC Med Inform Decis Mak"},{"key":"990_CR11","doi-asserted-by":"publisher","DOI":"10.1055\/s-0041-1731387","author":"G Tremper","year":"2021","unstructured":"Tremper G, Brenner T, Stampe F, et al. MAGICPL: a generic process description language for distributed pseudonymization scenarios. Methods Inf Med. 2021. https:\/\/doi.org\/10.1055\/s-0041-1731387.","journal-title":"Methods Inf Med"},{"key":"990_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-019-0167-7","author":"CM Booth","year":"2019","unstructured":"Booth CM, Karim S, Mackillop WJ. Real-world data: towards achieving the achievable in cancer care. Nat Rev Clin Oncol. 2019. https:\/\/doi.org\/10.1038\/s41571-019-0167-7.","journal-title":"Nat Rev Clin Oncol"},{"key":"990_CR13","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.9723","author":"JA Cook","year":"2015","unstructured":"Cook JA, Collins GS. The rise of big clinical databases. Br J Surg. 2015. https:\/\/doi.org\/10.1002\/bjs.9723.","journal-title":"Br J Surg"},{"key":"990_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s12874-021-01416-5","author":"MA Gianfrancesco","year":"2021","unstructured":"Gianfrancesco MA, Goldstein ND. A narrative review on the validity of electronic health record-based research in epidemiology. BMC Med Res Methodol. 2021. https:\/\/doi.org\/10.1186\/s12874-021-01416-5.","journal-title":"BMC Med Res Methodol"},{"key":"990_CR15","doi-asserted-by":"publisher","DOI":"10.1055\/s-0039-1693685","author":"D Ju\u00e1rez","year":"2019","unstructured":"Ju\u00e1rez D, Schmidt EE, Stahl-Toyota S, \u00dcckert F, Lablans M. A generic method and implementation to evaluate and improve data quality in distributed research networks. Methods Inf Med. 2019. https:\/\/doi.org\/10.1055\/s-0039-1693685.","journal-title":"Methods Inf Med"},{"key":"990_CR16","volume-title":"Manual of cancer registration in Germany","author":"C Stegmaier","year":"2019","unstructured":"Stegmaier C, Hentschel S, Hofst\u00e4dter F, Katalinic A, Tillack A, Klinkhammer-Schalke M. Manual of cancer registration in Germany. 2nd ed. Germany: Zuckschwerdt Verlag; 2019.","edition":"2"},{"key":"990_CR17","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyu188","author":"A Gaye","year":"2014","unstructured":"Gaye A, Marcon Y, Isaeva J, et al. DataSHIELD: taking the analysis to the data, not the data to the analysis. Int J Epidemiol. 2014. https:\/\/doi.org\/10.1093\/ije\/dyu188.","journal-title":"Int J Epidemiol"},{"key":"990_CR18","unstructured":"Moncada-Torres A, Martin F, Sieswerda M, van Soest J, Geleijnse G. VANTAGE6: an open source priVAcy preserviNg federaTed leArninG infrastructurE for Secure Insight eXchange. In: AMIA annual symposium proceedings 2020, pp. 870\u2013877."},{"key":"990_CR19","unstructured":"R: The R Project for Statistical Computing. https:\/\/www.r-project.org\/. Accessed 15 July 2022."},{"key":"990_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2012.02.017","author":"D Sarfati","year":"2012","unstructured":"Sarfati D. Review of methods used to measure comorbidity in cancer populations: no gold standard exists. J Clin Epidemiol. 2012. https:\/\/doi.org\/10.1016\/j.jclinepi.2012.02.017.","journal-title":"J Clin Epidemiol"},{"key":"990_CR21","doi-asserted-by":"publisher","unstructured":"Balzer M, Deussen O. Voronoi treemaps. In: Proceedings\u2014IEEE symposium on information visualization. INFOVIS. 2005. https:\/\/doi.org\/10.1109\/INFVIS.2005.1532128.","DOI":"10.1109\/INFVIS.2005.1532128"},{"key":"990_CR22","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1097\/00008469-200508000-00002","volume":"14","author":"MP Curado","year":"2005","unstructured":"Curado MP, Okamoto N, Ries L, et al. International rules for multiple primary cancers (ICD-0 third edition). Eur J Cancer Prev. 2005;14:307\u20138. https:\/\/doi.org\/10.1097\/00008469-200508000-00002.","journal-title":"Eur J Cancer Prev"},{"key":"990_CR23","unstructured":"Erdmann F, Spix C, Katalinic A, et al. Krebs in Deutschland F\u00fcr 2017\/2018. 13 ed. Robert Koch-Institut (Hrsg) und die Gesellschaft der epidemiologischen Krebsregister in Deutschland e.V. (Hrsg). 2021."},{"key":"990_CR24","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v22.i44.9694","author":"M Ilic","year":"2016","unstructured":"Ilic M, Ilic I. Epidemiology of pancreatic cancer. World J Gastroenterol. 2016. https:\/\/doi.org\/10.3748\/wjg.v22.i44.9694.","journal-title":"World J Gastroenterol"},{"key":"990_CR25","doi-asserted-by":"publisher","DOI":"10.1055\/s-0034-1390455","author":"O Bayer","year":"2015","unstructured":"Bayer O, Kr\u00fcger M, Koutsimpelas D, et al. Ver\u00e4nderung von Inzidenz und Mortalit\u00e4t von Kopf-Hals-Malignomen in Rheinland-Pfalz, 2000\u20132009. Laryngorhinootologie. 2015. https:\/\/doi.org\/10.1055\/s-0034-1390455.","journal-title":"Laryngorhinootologie"},{"key":"990_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-022-09731-w","author":"M Roessler","year":"2022","unstructured":"Roessler M, Schmitt J, Bobeth C, et al. Is treatment in certified cancer centers related to better survival in patients with pancreatic cancer? Evidence from a large German cohort study. BMC Cancer. 2022. https:\/\/doi.org\/10.1186\/s12885-022-09731-w.","journal-title":"BMC Cancer"},{"key":"990_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2020.102019","author":"AM Tsimberidou","year":"2020","unstructured":"Tsimberidou AM, Fountzilas E, Nikanjam M, Kurzrock R. Review of precision cancer medicine: evolution of the treatment paradigm. Cancer Treat Rev. 2020. https:\/\/doi.org\/10.1016\/j.ctrv.2020.102019.","journal-title":"Cancer Treat Rev"},{"key":"990_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01450-2","author":"M Wang","year":"2021","unstructured":"Wang M, Herbst RS, Boshoff C. Toward personalized treatment approaches for non-small-cell lung cancer. Nat Med. 2021. https:\/\/doi.org\/10.1038\/s41591-021-01450-2.","journal-title":"Nat Med"}],"container-title":["European Journal of Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10654-023-00990-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10654-023-00990-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10654-023-00990-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,6]],"date-time":"2023-05-06T05:09:17Z","timestamp":1683349757000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10654-023-00990-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,5]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["990"],"URL":"https:\/\/doi.org\/10.1007\/s10654-023-00990-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2162340\/v1","asserted-by":"object"}]},"ISSN":["0393-2990","1573-7284"],"issn-type":[{"value":"0393-2990","type":"print"},{"value":"1573-7284","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,5]]},"assertion":[{"value":"13 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Daniel Maier (DM) received speaker honoraria from Free University of Berlin. J\u00f6rg Janne Vehreschild (JJV) has personal fees from Merck\/MSD, Gilead, Pfizer, Astellas Pharma, Basilea, German Centre for Infection Research (DZIF), University Hospital Freiburg\/Congress and Communication, Academy for Infectious Medicine, University Manchester, German Society for Infectious Diseases (DGI), \u00c4rztekammer Nordrhein, University Hospital Aachen, Back Bay Strategies, German Society for Internal Medicine (DGIM), Shionogi, Molecular Health, Netzwerk Universit\u00e4tsmedizin, Janssen, NordForsk, and grants from Merck\/MSD, Gilead, Pfizer, Astellas Pharma, Basilea, German Centre for Infection Research (DZIF), German Federal Ministry of Education and Research (BMBF), Deutsches Zetrum f\u00fcr Luft- und Raumfahrt (DLR), University of Bristol, Rigshospitalet Copenhagen. Viktor Gr\u00fcnwald (VG) received honoraria for consulting and appraisal work from Bristol-Myers Squibb, Pfizer, Novartis, MSD Oncology, Ipsen, Janssen-Cilag, Onkowissen, CORE2ED, Eisai, and Debiopharm. VG owns stocks or options of MSD, Bristol-Myers Squibb, AstraZeneca, Seagen, and Genmab. VG has personal fees from from Bristol-Myers Squibb, Pfizer, Novartis, Ipsen, Eisai, MSD Oncology, Merck Serono, Roche, AstraZeneca, EUSAPharm, Janssen-Cilag, AAA\/Novartis, Apogepha, Nanobiotix, ClinSol and Ono Pharmaceutical. VG received funding for scientific research from Novartis, Amgen, MSD Oncology, BMS, Seattle Genetics and Ipsen. He also has non-financial connections to Bristol-Myers Squibb, Pfizer and AstraZeneca. Boris Hadaschik (BH) has had advisory roles for ABX, AAA\/Novartis, Astellas, AstraZeneca, Bayer, Bristol Myers Squibb, Janssen R&D, Lightpoint Medical, Inc., and Pfizer; BH received research funding from Astellas, Bristol Myers Squibb, AAA\/Novartis, German Research Foundation, Janssen R&D, and Pfizer; and has received compensation for travel from Astellas, AstraZeneca, Bayer and Janssen R&D. Susanne Singer (SS) received honoraria from Lilly, Eisei and Pfizer; she received funding for scientific research from the German Cancer Aid, G-BA, EORTC, and the EU. SS conducted unpaid consulting and appraisal work for the University Hospital Hamburg (CAYA Study) and is a member of the scientific advisory board for patient associations (head and neck cancer, thyroid cancer; unpaid). Martin Stuschke (MSt) received honoraria for consulting and appraisal work from AstraZeneca, Bristol-Myers Squibb, Sanofi-Aventis, Janssen-Cilag, and AOK Rheinland\/Hamburg. MSt has personal fees from Medupdate and received funding for scientific research from AstraZeneca. Kristina Ihrig (KI) received honoraria from the German Cancer Consortium. Martin Schuler (MSc) received payment for consulting and appraisal work from Amgen, AstraZeneca, BIOCAD, Boehringer Ingelheim, Bristol-Myers Squibb, GlaxoSmithKline, Janssen, Merck Serono, Novartis, Roche, Sanofi, Takeda, BMS, GSK. MSc has personal fees from Amgen, Boehringer Ingelheim, Bristol-Myers Squibb, Janssen and Novartis. He received funding for scientific research from AstraZeneca, Bristol Myers-Squibb and has personal fees from BIOCAD, BMS, Boehringer Ingelheim, Janssen, Novartis. Thomas Oellerich (TO) received payment for consulting and appraisal work from Roche and Merck KGaA. TO holds patent, copyright or licensing rights with the Max-Planck-Institute and the Goethe University Frankfurt. TO received funding for scientific research from Gilead and Merck KGaA. Anna L. Illert (ALI) received honoraria for consulting and appraisal work from AbbVie, Janssen-Cilag and Takeda. She has personal fees from Roche, AstraZeneca, Ars Tempi and Takeda; ALI received funding for scientific research from German Cancer Aid. ALI has personal fees from Roche, AstraZeneca, Janssen-Cilag, and Takeda. Wilko Weichert (WW) received honoraria from Roche, MSD, BMS, AstraZeneca, Pfizer, Merck, Lilly, Boehringer, Novartis, Takeda, Bayer, Janssen, Amgen, Astellas, Illumina, Eisai, Siemens, Agilent, ADC, GSK, and Molecular Health. WW received funding for scientific research from Roche, MSD, BMS, AstraZeneca. Michael von Bergwelt-Baildon (MBB) received payment for consulting and appraisal work from AMGEN, MSD Sharp & Dohme, Novartis, Roche, KITE\/Gilead, Bristol-Myers Squibb, Astellas, Mologen and Miltenyi. He has personal fees from AMGEN, MSD Sharp & Dohme, Novartis, Roche, KITE\/Gilead, Bristol-Myers Squibb, Astellas, Mologen and Miltenyi. MBB received funding for scientific research from AMGEN, MSD Sharp & Dohme, Novartis, Roche, KITE\/Gilead, Bristol-Myers Squibb, Astellas, Mologen and Miltenyi. MBB has financial connections to AMGEN, MSD Sharp & Dohme, Novartis, Roche, KITE\/Gilead, Bristol-Myers Squibb, Astellas, Mologen and Miltenyi. Michael Bitzer (MB) received honoraria for consulting and appraisal work from Roche Pharma AG, Incyte Biosciences Germany GmbH, Bayer Vital GmbH, Bristol-Myers Squibb GmbH & Co KgaA and MSD Sharp & Dome GmbH. MB has personal fees from MSD Sharp & Dome GmbH. Melanie Janning (MJ) received honoraria for consulting and appraisal work from Roche, Boehringer, Amgen, AstraZeneca and Novartis. MJ has personal fees from Roche, Boehringer, Amgen, AstraZeneca and Novartis. MJ received funding for scientific research from the Margarete Clemens Foundation, the Hector Foundation II and Landesforschungsf\u00f6rderung Hamburg. Sonja Loges (SL) received honoraria for consulting and appraisal work from BerGenBio, BMS, Roche Pharma, Boehringer Ingelheim, Eli Lilly, Medac GmbH, Sanofi, Novartis, Pfizer, AstraZeneca, Takeda, Amgen, Bayer, Janssen and Merck. She has personal fees from BerGenBio, BMS, Roche Pharma, Boehringer Ingelheim, Eli Lilly, Medac GmbH, Sanofi, Novartis, Pfizer, AstraZeneca, Takeda, Amgen, Bayer, Janssen and Merck. SL received funding for scientific research from European Union (ERC), the German Research Foundation (DFG), the German Cancer Aid, the Margarete Clemens Foundation, the Hector Foundation II and Landesforschungsf\u00f6rderung Hamburg. Eugen Tausch (ET) received payment for consulting and appraisal work from Abbvie, BeiGene, Jannsen-Cilag and Roche. He received honoraria from Abbvie, AstraZeneca, BeiGene, Jannsen and Roche. ET received funding for scientific research from Abbvie, Gilead and Roche. He has financial connections to Abbvie and Jannsen-Cilag. Michael Neumann\u00a0(MN) received honoraria from BBMRI-ERIC. Hubert Serve (HS) received honoraria for consulting from Novartis, Gilead and Abbvie, and research funding from Merck KGaA.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}},{"value":"The cohort profile relies on retrospective, aggregated, non-personal patient data obtained for clinical purposes. Therefore, law requires neither ethics vote nor informed consent. An approval of the project was given by ten participating centers (ethics committees of seven centers independently approved the project, three more centers accepted the initial vote).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}